These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38860471)
1. Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control Study. Grut V; Biström M; Salzer J; Stridh P; Jons D; Gustafsson R; Huang J; Bergström T; Kockum I; Waterboer T; Olsson T; Sundström P Ann Neurol; 2024 Aug; 96(2):302-305. PubMed ID: 38860471 [TBL] [Abstract][Full Text] [Related]
2. Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis. Engdahl E; Gustafsson R; Huang J; Biström M; Lima Bomfim I; Stridh P; Khademi M; Brenner N; Butt J; Michel A; Jons D; Hortlund M; Alonso-Magdalena L; Hedström AK; Flamand L; Ihira M; Yoshikawa T; Andersen O; Hillert J; Alfredsson L; Waterboer T; Sundström P; Olsson T; Kockum I; Fogdell-Hahn A Front Immunol; 2019; 10():2715. PubMed ID: 32038605 [TBL] [Abstract][Full Text] [Related]
3. Evolution of antibody titres against Epstein-Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patients. Pérez-Pérez S; Cuello JP; Martínez-Ginés M; Pardo-Rodríguez B; García-Domínguez JM; Domínguez-Mozo MI; Lozano-Ros A; García-Martínez MÁ; Higueras Y; Meldaña-Rivera A; Goicochea-Briceño H; Tejeda-Velarde A; Fernández-Velasco JI; Medina S; Arroyo R; Villar LM; Álvarez-Lafuente R Sci Rep; 2021 Apr; 11(1):8441. PubMed ID: 33875702 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples. Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431 [TBL] [Abstract][Full Text] [Related]
5. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321 [TBL] [Abstract][Full Text] [Related]
6. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis. Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM Front Immunol; 2021; 12():757302. PubMed ID: 34790199 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. DeLorenze GN; Munger KL; Lennette ET; Orentreich N; Vogelman JH; Ascherio A Arch Neurol; 2006 Jun; 63(6):839-44. PubMed ID: 16606758 [TBL] [Abstract][Full Text] [Related]
18. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. Jog NR; McClain MT; Heinlen LD; Gross T; Towner R; Guthridge JM; Axtell RC; Pardo G; Harley JB; James JA J Autoimmun; 2020 Jan; 106():102332. PubMed ID: 31515129 [TBL] [Abstract][Full Text] [Related]
19. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621 [TBL] [Abstract][Full Text] [Related]
20. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study. Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]